Detalhe da pesquisa
1.
The Oral ß-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies.
Antimicrob Agents Chemother
; 61(3)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28052855
2.
Vilazodone lacks proarrhythmogenic potential in healthy participants: a thorough ECG study.
Int J Clin Pharmacol Ther
; 51(6): 456-65, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23611569
3.
Effect of the rate of niacin administration on the plasma and urine pharmacokinetics of niacin and its metabolites.
J Clin Pharmacol
; 47(6): 681-8, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17463214
4.
Pharmacokinetics of vilazodone in patients with mild or moderate renal impairment.
Clin Drug Investig
; 33(3): 199-206, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23417352